Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice. (2019)
Attributed to:
Enabling technologies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41434-018-0052-5
PubMed Identifier: 30514969
Publication URI: http://europepmc.org/abstract/MED/30514969
Type: Journal Article/Review
Volume: 26
Parent Publication: Gene therapy
Issue: 1-2
ISSN: 0969-7128